I bought Investor's Business Daily (IBD) for Monday and used their IBD 100 list to formulate a watchlist moving forward into earnings. The stocks I have identified for either positive/negative reasons are:
*VistaPrint Ltd. (VPRT)
*Green Mountain Coffee Roasters INC (GMCR)
*Panera Bread Co.(PNRA)
*Thoratec Corp (THOR)
*Visa (V)
*Granite Construction INC (GVA)
*Edwards Lifesciences Corp (EW)
*American Italian Pasta Co.(AIPC)
Trials and tribulations of my stock trading and investing experiences. Lessons learned, both good and bad...that will hopefully benefit others.

Custom Search
Showing posts with label IBD 100. Show all posts
Showing posts with label IBD 100. Show all posts
Sunday, April 05, 2009
Sunday, January 20, 2008
IBD Healthcare Update
Went over the latest IBD and it looks like the healthcare has advanced according to IBD, however I am not willing to take it at strictly face value which I will explain. This week there is 11 healthcare-related industries within the top 25 a whopping 44% representation and they are:
#2 Medical/Dental-Services
#3 Medical-Ethical Drugs
#5 Medical-Genetics
#6 Medical-Systems/Equipment
#12 Medical-Health Maintenance Organizations
#13 Medical-Products
#15 Medical-Wholesale Drug/Supply
#16 Medical-Drug/Diversified
#17 Medical-Outpatient/Home Care
#18 Medical-Biomed/Biotech
#24 Medical-Generic/Drugs
This sounds and looks great on the surface, however here is my concern. I sometimes use the IBD 100 to help focus on some momentum stocks and have a set of criteria I follow with regards to overall stock rank and group ranking. Normally, I will have my steady performers who are always on the list in one form or another i.e. POT, ISRG, VIP etc...However this week there was a tremendous amount of new companies into my numbers on the order of +35%, which is not normal. I find during volatile times some companies make a big move one week, so they find themselves into my numbers, but drop out shortly thereafter.
So you may ask...How does this all tie into healthcare? Well, 8 of the 20 new entries are related to the healthcare industry, so I am a bit hesitant and have a gut feeling that there may be more "pain" to follow. Here are those new entries
1. Yamana Gold INC (AUY)
2. Blackrock (BLK)
3. American Public Education INC (APEI)
4. Omnicell (OMCL) (I do own shares of this company)
5. Flir Systems INC (FLIR)
6. Amedisys (AMED)
7. Energen (EGN)
8. Strayer Education (STRA)
9. Invitrogen (IVGN)
10. Icon Plc ADS (ICLR)
11. Covance (CVD)
12. Mechel Oao ADS (MTL)
13. Stericycle (SRCL)
14. Genzyme Corp (GENZ)
15. Berkshire Hathaway A (BRKA)
16. Kendle Intl (KNDL)
17. Apollo Group A (APOL)
18. Cellcom Israel Ltd (CEL)
19. Axsys Tech (AXYS)
20. Continental Res INC (CLR)
#2 Medical/Dental-Services
#3 Medical-Ethical Drugs
#5 Medical-Genetics
#6 Medical-Systems/Equipment
#12 Medical-Health Maintenance Organizations
#13 Medical-Products
#15 Medical-Wholesale Drug/Supply
#16 Medical-Drug/Diversified
#17 Medical-Outpatient/Home Care
#18 Medical-Biomed/Biotech
#24 Medical-Generic/Drugs
This sounds and looks great on the surface, however here is my concern. I sometimes use the IBD 100 to help focus on some momentum stocks and have a set of criteria I follow with regards to overall stock rank and group ranking. Normally, I will have my steady performers who are always on the list in one form or another i.e. POT, ISRG, VIP etc...However this week there was a tremendous amount of new companies into my numbers on the order of +35%, which is not normal. I find during volatile times some companies make a big move one week, so they find themselves into my numbers, but drop out shortly thereafter.
So you may ask...How does this all tie into healthcare? Well, 8 of the 20 new entries are related to the healthcare industry, so I am a bit hesitant and have a gut feeling that there may be more "pain" to follow. Here are those new entries
1. Yamana Gold INC (AUY)
2. Blackrock (BLK)
3. American Public Education INC (APEI)
4. Omnicell (OMCL) (I do own shares of this company)
5. Flir Systems INC (FLIR)
6. Amedisys (AMED)
7. Energen (EGN)
8. Strayer Education (STRA)
9. Invitrogen (IVGN)
10. Icon Plc ADS (ICLR)
11. Covance (CVD)
12. Mechel Oao ADS (MTL)
13. Stericycle (SRCL)
14. Genzyme Corp (GENZ)
15. Berkshire Hathaway A (BRKA)
16. Kendle Intl (KNDL)
17. Apollo Group A (APOL)
18. Cellcom Israel Ltd (CEL)
19. Axsys Tech (AXYS)
20. Continental Res INC (CLR)
Labels:
biomedical,
drug,
generic,
healthcare,
ibd,
IBD 100,
medical,
stocks
Subscribe to:
Posts (Atom)